Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.8M Buy
47,817
+13,622
+40% +$3.77M 4.93% 6
2025
Q4
$9.41M Buy
34,195
+11,695
+52% +$3.28M 5.17% 8
2025
Q3
$6.49M Buy
22,500
+11,600
+106% +$3.43M 3.69% 12
2025
Q2
$3.6M Sell
10,900
-1,250
-10% -$403K 2.78% 16
2025
Q1
$4M Buy
12,150
+3,900
+47% +$1.17M 3.42% 12
2024
Q4
$2.28M Buy
+8,250
New +$2.63M 2.23% 19
2022
Q3
$2.57M Hold
9,250
4.28% 9
2022
Q2
$2.44M Sell
9,250
-3,000
-24% -$773K 3.82% 13
2022
Q1
$2.94M Buy
12,250
+1,000
+9% +$234K 4.09% 10
2021
Q4
$2.58M Hold
11,250
3.11% 10
2021
Q3
$2.25M Hold
11,250
4.22% 11
2021
Q2
$2.67M Sell
11,250
-17,850
-61% -$4.46M 4.8% 10
2021
Q1
$6.49M Buy
29,100
+12,750
+78% +$2.84M 6.68% 6
2020
Q4
$3.4M Hold
16,350
6.91% 4
2020
Q3
$2.77M Sell
16,350
-2,190
-12% -$385K 6.68% 5
2020
Q2
$3.48M Sell
18,540
-5,000
-21% -$949K 7.63% 5
2020
Q1
$4.17M Sell
23,540
-5,250
-18% -$1.02M 7.84% 2
2019
Q4
$5.89M Sell
28,790
-2,500
-8% -$458K 6.17% 4
2019
Q3
$4.75M Buy
31,290
+25
+0.1% +$4.07K 5.23% 9
2019
Q2
$4.93M Buy
31,265
+16,270
+109% +$2.55M 5.53% 6
2019
Q1
$2.41M Buy
14,995
+12,746
+567% +$2.33M 2.83% 17
2018
Q4
$427K Buy
+2,249
New +$469K 0.55% 28

Other funds holding CI

Colrain Capital's CI Position: Q1 2026 in Review

Colrain Capital increased its Cigna (CI) stake by 40% in Q1 2026, buying an estimated $3.77M and bringing the position to 47,817 shares worth $12.8M. The position accounts for 4.93% of the portfolio, ranked #6.

Colrain Capital first reported a position in CI in Q4 2018 and has held it in 22 quarters since. 1,654 funds tracked by Wall St. Rank hold CI as of Q1 2026.

  • Colrain Capital held 47,817 shares of Cigna worth $12.8M as of Q1 2026.
  • Colrain Capital bought 13,622 Cigna shares in Q1 2026, an estimated $3.77M.
  • Cigna made up 4.93% of Colrain Capital's portfolio in Q1 2026, its #6 holding.
  • Colrain Capital first reported a position in Cigna in Q4 2018 and has held it in 22 quarters since.
  • 1,654 funds tracked by Wall St. Rank held Cigna as of Q1 2026.

Based on Colrain Capital's 13F filing for Q1 2026, filed 12 May 2026.